Table of Content


Chapter 1 Methodology
1.1 Methodology
1.2 Market definitions
1.3 Forecast parameters
1.4 Data sources
1.4.1 Secondary
1.4.1.1 Paid sources
1.4.1.2 Unpaid sources
1.4.2 Primary
Chapter 2 Executive Summary
2.1 Onychomycosis treatment industry 360 degree synopsis, 2016 - 2027
2.1.1 Business trends
2.1.2 Type trends
2.1.3 Treatment type trends
2.1.4 Drug class trends
2.1.5 Distribution channel trends
2.1.6 Regional trends
Chapter 3 Onychomycosis Treatment Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2016 - 2027
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing prevalence of diabetes worldwide
3.3.1.2 Growing awareness about the potential threats of onychomycosis
3.3.1.3 Rising prevalence of onychomycosis in adults and elderly population
3.3.2 Industry pitfalls and challenges
3.3.2.1 Side effects associated with onychomycosis treatment drugs
3.4 Growth potential analysis
3.4.1 By type
3.4.2 By treatment type
3.4.3 By drug class
3.4.4 By distribution channel
3.5 COVID-19 impact analysis
3.6 Porter’s analysis
3.7 Competitive landscape, 2020
3.7.1 Competitive matrix analysis, 2020
3.8 PESTEL analysis
Chapter 4 Onychomycosis Treatment Market, By Type
4.1 Key segment trends
4.2 Distal Subungual Onychomycosis (DSO)
4.2.1 Market size, by region, 2016 - 2027
4.3 White Superficial Onychomycosis (WSO)
4.3.1 Market size, by region, 2016 - 2027
4.4 Proximal Subungual Onychomycosis (PSO)
4.4.1 Market size, by region, 2016 - 2027
4.5 Candida Onychomycosis
4.5.1 Market size, by region, 2016 - 2027
4.6 Others
4.6.1 Market size, by region, 2016 - 2027
Chapter 5 Onychomycosis Treatment Market, By Treatment Type
5.1 Key segment trends
5.2 Drug treatment
5.2.1 Market size, by region, 2016 - 2027
5.3 Topical therapy
5.3.1 Market size, by region, 2016 - 2027
Chapter 6 Onychomycosis Treatment Market, By Drug Class
6.1 Key segment trends
6.2 Allylamine
6.2.1 Market size, by region, 2016 - 2027
6.3 Azole
6.3.1 Market size, by region, 2016 - 2027
6.4 Griseofulvin
6.4.1 Market size, by region, 2016 - 2027
6.5 Others
6.5.1 Market size, by region, 2016 - 2027
Chapter 7 Onychomycosis Treatment Market, By Distribution Channel
7.1 Key segment trends
7.2 Hospital Pharmacies
7.2.1 Market size, by region, 2016 - 2027
7.3 Retail Pharmacies
7.3.1 Market size, by region, 2016 - 2027
7.4 Online pharmacies
7.4.1 Market size, by region, 2016 - 2027
Chapter 8 Onychomycosis Treatment Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 Market size, by country 2016 - 2027
8.2.2 Market size, by type, 2016 - 2027
8.2.3 Market size, by treatment type, 2016 - 2027
8.2.4 Market size, by drug class, 2016 - 2027
8.2.5 Market size, by distribution channel, 2016 - 2027
8.2.6 U.S.
8.2.6.1 Market size, by type, 2016 - 2027
8.2.6.2 Market size, by treatment type, 2016 - 2027
8.2.6.3 Market size, by drug class, 2016 - 2027
8.2.6.4 Market size, by distribution channel, 2016 - 2027
8.2.7 Canada
8.2.7.1 Market size, by type, 2016 - 2027
8.2.7.2 Market size, by treatment type, 2016 - 2027
8.2.7.3 Market size, by drug class, 2016 - 2027
8.2.7.4 Market size, by distribution channel, 2016 - 2027
8.3 Europe
8.3.1 Market size, by country 2016 - 2027
8.3.2 Market size, by type, 2016 - 2027
8.3.3 Market size, by treatment type, 2016 - 2027
8.3.4 Market size, by drug class, 2016 - 2027
8.3.5 Market size, by distribution channel, 2016 - 2027
8.3.6 Germany
8.3.6.1 Market size, by type, 2016 - 2027
8.3.6.2 Market size, by treatment type, 2016 - 2027
8.3.6.3 Market size, by drug class, 2016 - 2027
8.3.6.4 Market size, by distribution channel, 2016 - 2027
8.3.7 France
8.3.7.1 Market size, by type, 2016 - 2027
8.3.7.2 Market size, by treatment type, 2016 - 2027
8.3.7.3 Market size, by drug class, 2016 - 2027
8.3.7.4 Market size, by distribution channel, 2016 - 2027
8.3.8 UK
8.3.8.1 Market size, by type, 2016 - 2027
8.3.8.2 Market size, by treatment type, 2016 - 2027
8.3.8.3 Market size, by drug class, 2016 - 2027
8.3.8.4 Market size, by distribution channel, 2016 - 2027
8.3.9 Italy
8.3.9.1 Market size, by type, 2016 - 2027
8.3.9.2 Market size, by treatment type, 2016 - 2027
8.3.9.3 Market size, by drug class, 2016 - 2027
8.3.9.4 Market size, by distribution channel, 2016 - 2027
8.3.10 Spain
8.3.10.1 Market size, by type, 2016 - 2027
8.3.10.2 Market size, by treatment type, 2016 - 2027
8.3.10.3 Market size, by drug class, 2016 - 2027
8.3.10.4 Market size, by distribution channel, 2016 - 2027
8.4 Asia Pacific
8.4.1 Market size, by country 2016 - 2027
8.4.2 Market size, by type, 2016 - 2027
8.4.3 Market size, by treatment type, 2016 - 2027
8.4.4 Market size, by drug class, 2016 - 2027
8.4.5 Market size, by distribution channel, 2016 - 2027
8.4.6 China
8.4.6.1 Market size, by type, 2016 - 2027
8.4.6.2 Market size, by treatment type, 2016 - 2027
8.4.6.3 Market size, by drug class, 2016 - 2027
8.4.6.4 Market size, by distribution channel, 2016 - 2027
8.4.7 Japan
8.4.7.1 Market size, by type, 2016 - 2027
8.4.7.2 Market size, by treatment type, 2016 - 2027
8.4.7.3 Market size, by drug class, 2016 - 2027
8.4.7.4 Market size, by distribution channel, 2016 - 2027
8.4.8 India
8.4.8.1 Market size, by type, 2016 - 2027
8.4.8.2 Market size, by treatment type, 2016 - 2027
8.4.8.3 Market size, by drug class, 2016 - 2027
8.4.8.4 Market size, by distribution channel, 2016 - 2027
8.4.9 South Korea
8.4.9.1 Market size, by type, 2016 - 2027
8.4.9.2 Market size, by treatment type, 2016 - 2027
8.4.9.3 Market size, by drug class, 2016 - 2027
8.4.9.4 Market size, by distribution channel, 2016 - 2027
8.4.10 Australia
8.4.10.1 Market size, by type, 2016 - 2027
8.4.10.2 Market size, by treatment type, 2016 - 2027
8.4.10.3 Market size, by drug class, 2016 - 2027
8.4.10.4 Market size, by distribution channel, 2016 - 2027
8.5 Latin America
8.5.1 Market size, by country 2016 - 2027
8.5.2 Market size, by type, 2016 - 2027
8.5.3 Market size, by treatment type, 2016 - 2027
8.5.4 Market size, by drug class, 2016 - 2027
8.5.5 Market size, by distribution channel, 2016 - 2027
8.5.6 Brazil
8.5.6.1 Market size, by type, 2016 - 2027
8.5.6.2 Market size, by treatment type, 2016 - 2027
8.5.6.3 Market size, by drug class, 2016 - 2027
8.5.6.4 Market size, by distribution channel, 2016 - 2027
8.5.7 Mexico
8.5.7.1 Market size, by type, 2016 - 2027
8.5.7.2 Market size, by treatment type, 2016 - 2027
8.5.7.3 Market size, by drug class, 2016 - 2027
8.5.7.4 Market size, by distribution channel, 2016 - 2027
8.5.8 Argentina
8.5.8.1 Market size, by type, 2016 - 2027
8.5.8.2 Market size, by treatment type, 2016 - 2027
8.5.8.3 Market size, by drug class, 2016 - 2027
8.5.8.4 Market size, by distribution channel, 2016 - 2027
8.6 Middle East and Africa
8.6.1 Market size, by country 2016 - 2027
8.6.2 Market size, by type, 2016 - 2027
8.6.3 Market size, by treatment type, 2016 - 2027
8.6.4 Market size, by drug class, 2016 - 2027
8.6.5 Market size, by distribution channel, 2016 - 2027
8.6.6 Saudi Arabia
8.6.6.1 Market size, by type, 2016 - 2027
8.6.6.2 Market size, by treatment type, 2016 - 2027
8.6.6.3 Market size, by drug class, 2016 - 2027
8.6.6.4 Market size, by distribution channel, 2016 - 2027
8.6.7 UAE
8.6.7.1 Market size, by type, 2016 - 2027
8.6.7.2 Market size, by treatment type, 2016 - 2027
8.6.7.3 Market size, by drug class, 2016 - 2027
8.6.7.4 Market size, by distribution channel, 2016 - 2027
8.6.8 South Africa
8.6.8.1 Market size, by type, 2016 - 2027
8.6.8.2 Market size, by treatment type, 2016 - 2027
8.6.8.3 Market size, by drug class, 2016 - 2027
8.6.8.4 Market size, by distribution channel, 2016 - 2027
Chapter 9 Company Profiles
9.1 Strategy dashboard, 2020
9.2 Novartis AG
9.2.1 Business overview
9.2.2 Financial data
9.2.3 Product landscape
9.2.4 Strategic outlook
9.2.5 SWOT analysis
9.3 Pfizer Inc.
9.3.1 Business overview
9.3.2 Financial data
9.3.3 Product landscape
9.3.4 Strategic outlook
9.3.5 SWOT analysis
9.4 Galderma Laboratories
9.4.1 Business overview
9.4.2 Financial data
9.4.3 Product landscape
9.4.4 Strategic outlook
9.4.5 SWOT analysis
9.5 Bausch Health Sciences
9.5.1 Business overview
9.5.2 Financial data
9.5.3 Product landscape
9.5.4 Strategic outlook
9.5.5 SWOT analysis
9.6 Moberg Pharma AB
9.6.1 Business overview
9.6.2 Financial data
9.6.3 Product landscape
9.6.4 Strategic outlook
9.6.5 SWOT analysis
9.7 Dr. Reddy’s Laboratories Ltd
9.7.1 Business overview
9.7.2 Financial data
9.7.3 Product landscape
9.7.4 Strategic outlook
9.7.5 SWOT analysis
9.8 Medimetriks Pharmaceuticals Inc.
9.8.1 Business overview
9.8.2 Financial data
9.8.3 Product landscape
9.8.4 Strategic outlook
9.8.5 SWOT analysis
9.9 Merz Pharma
9.9.1 Business overview
9.9.2 Financial data
9.9.3 Product landscape
9.9.4 Strategic outlook
9.9.5 SWOT analysis
9.10 Kaken Pharmaceutical Co. Ltd
9.10.1 Business overview
9.10.2 Financial data
9.10.3 Product landscape
9.10.4 Strategic outlook
9.10.5 SWOT analysis
9.11 Johnson & Johnson Services Inc.
9.11.1 Business overview
9.11.2 Financial data
9.11.3 Product landscape
9.11.4 Strategic outlook
9.11.5 SWOT analysis
9.12 GlaxoSmithKline plc
9.12.1 Business overview
9.12.2 Financial data
9.12.3 Product landscape
9.12.4 Strategic outlook
9.12.5 SWOT analysis
9.13 Taro Pharmaceuticals Industries Ltd
9.13.1 Business overview
9.13.2 Financial data
9.13.3 Product landscape
9.13.4 Strategic outlook
9.13.5 SWOT analysis



List of Tables

Data Tables
TABLE 1 Onychomycosis treatment industry 360 degree synopsis, 2016 - 2027
TABLE 2 Onychomycosis treatment market, 2016-2027 (USD Million)
TABLE 3 Onychomycosis treatment market, by type, 2016-2027 (USD Million)
TABLE 4 Onychomycosis treatment market, by treatment type, 2016-2027 (USD Million)
TABLE 5 Onychomycosis treatment market, by drug class, 2016-2027 (USD Million)
TABLE 6 Onychomycosis treatment market, by distribution channel, 2016-2027 (USD Million)
TABLE 7 Onychomycosis treatment market, by region, 2016-2027 (USD Million)
TABLE 8 Industry impact forces
TABLE 9 Distal subungual onychomycosis (DSO) market size, by region, 2016-2027 (USD Million)
TABLE 10 White superficial onychomycosis (WSO) market size, by region, 2016-2027 (USD Million)
TABLE 11 Proximal subungual onychomycosis (PSO) market size, by region, 2016-2027 (USD Million)
TABLE 12 Candida onychomycosis market size, by region, 2016-2027 (USD Million)
TABLE 13 Others market size, by region, 2016-2027 (USD Million)
TABLE 14 Drug treatment market size, by region, 2016-2027 (USD Million)
TABLE 15 Topical therapy market size, by region, 2016-2027 (USD Million)
TABLE 16 Allylamine market size, by region, 2016-2027 (USD Million)
TABLE 17 Azole market size, by region, 2016-2027 (USD Million)
TABLE 18 Griseofulvin market size, by region, 2016-2027 (USD Million)
TABLE 19 Others market size, by region, 2016-2027 (USD Million)
TABLE 20 Hospital pharmacies market size, by region, 2016-2027 (USD Million)
TABLE 21 Retail pharmacies market size, by region, 2016-2027 (USD Million)
TABLE 22 Online pharmacies market size, by region, 2016-2027 (USD Million)
TABLE 23 North America onychomycosis treatment market size, by country, 2016-2027 (USD Million)
TABLE 24 North America onychomycosis treatment market size, by type, 2016-2027 (USD Million)
TABLE 25 North America onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)
TABLE 26 North America onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)
TABLE 27 North America onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)
TABLE 28 U.S. onychomycosis treatment market size, by type, 2016-2027 (USD Million)
TABLE 29 U.S. onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)
TABLE 30 U.S. onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)
TABLE 31 U.S. onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)
TABLE 32 Canada onychomycosis treatment market size, by type, 2016-2027 (USD Million)
TABLE 33 Canada onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)
TABLE 34 Canada onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)
TABLE 35 Canada onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)
TABLE 36 Europe onychomycosis treatment market size, by country, 2016-2027 (USD Million)
TABLE 37 Europe onychomycosis treatment market size, by type, 2016-2027 (USD Million)
TABLE 38 Europe onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)
TABLE 39 Europe onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)
TABLE 40 Europe onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)
TABLE 41 Germany onychomycosis treatment market size, by type, 2016-2027 (USD Million)
TABLE 42 Germany onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)
TABLE 43 Germany onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)
TABLE 44 Germany onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)
TABLE 45 France onychomycosis treatment market size, by type, 2016-2027 (USD Million)
TABLE 46 France onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)
TABLE 47 France onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)
TABLE 48 France onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)
TABLE 49 UK onychomycosis treatment market size, by type, 2016-2027 (USD Million)
TABLE 50 UK onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)
TABLE 51 UK onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)
TABLE 52 UK onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)
TABLE 53 Italy onychomycosis treatment market size, by type, 2016-2027 (USD Million)
TABLE 54 Italy onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)
TABLE 55 Italy onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)
TABLE 56 Italy onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)
TABLE 57 Spain onychomycosis treatment market size, by type, 2016-2027 (USD Million)
TABLE 58 Spain onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)
TABLE 59 Spain onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)
TABLE 60 Spain onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)
TABLE 61 Asia Pacific onychomycosis treatment market size, by country, 2016-2027 (USD Million)
TABLE 62 Asia Pacific onychomycosis treatment market size, by type, 2016-2027 (USD Million)
TABLE 63 Asia Pacific onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)
TABLE 64 Asia Pacific onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)
TABLE 65 Asia Pacific onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)
TABLE 66 China onychomycosis treatment market size, by type, 2016-2027 (USD Million)
TABLE 67 China onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)
TABLE 68 China onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)
TABLE 69 China onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)
TABLE 70 Japan onychomycosis treatment market size, by type, 2016-2027 (USD Million)
TABLE 71 Japan onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)
TABLE 72 Japan onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)
TABLE 73 Japan onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)
TABLE 74 India onychomycosis treatment market size, by type, 2016-2027 (USD Million)
TABLE 75 India onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)
TABLE 76 India onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)
TABLE 77 India onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)
TABLE 78 South Korea onychomycosis treatment market size, by type, 2016-2027 (USD Million)
TABLE 79 South Korea onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)
TABLE 80 South Korea onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)
TABLE 81 South Korea onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)
TABLE 82 Australia onychomycosis treatment market size, by type, 2016-2027 (USD Million)
TABLE 83 Australia onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)
TABLE 84 Australia onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)
TABLE 85 Australia onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)
TABLE 86 Latin America onychomycosis treatment market size, by country, 2016-2027 (USD Million)
TABLE 87 Latin America onychomycosis treatment market size, by type, 2016-2027 (USD Million)
TABLE 88 Latin America onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)
TABLE 89 Latin America onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)
TABLE 90 Latin America onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)
TABLE 91 Brazil onychomycosis treatment market size, by type, 2016-2027 (USD Million)
TABLE 92 Brazil onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)
TABLE 93 Brazil onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)
TABLE 94 Brazil onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)
TABLE 95 Mexico onychomycosis treatment market size, by type, 2016-2027 (USD Million)
TABLE 96 Mexico onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)
TABLE 97 Mexico onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)
TABLE 98 Mexico onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)
TABLE 99 Argentina onychomycosis treatment market size, by type, 2016-2027 (USD Million)
TABLE 100 Argentina onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)
TABLE 101 Argentina onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)
TABLE 102 Argentina onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)
TABLE 103 MEA onychomycosis treatment market size, by country, 2016-2027 (USD Million)
TABLE 104 MEA onychomycosis treatment market size, by type, 2016-2027 (USD Million)
TABLE 105 MEA onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)
TABLE 106 MEA onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)
TABLE 107 MEA onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)
TABLE 108 Saudi Arabia onychomycosis treatment market size, by type, 2016-2027 (USD Million)
TABLE 109 Saudi Arabia onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)
TABLE 110 Saudi Arabia onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)
TABLE 111 Saudi Arabia onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)
TABLE 112 UAE onychomycosis treatment market size, by type, 2016-2027 (USD Million)
TABLE 113 UAE onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)
TABLE 114 UAE onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)
TABLE 115 UAE onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)
TABLE 116 South Africa onychomycosis treatment market size, by type, 2016-2027 (USD Million)
TABLE 117 South Africa onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)
TABLE 118 South Africa onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)
TABLE 119 South Africa onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)

Charts & Figures
FIG. 1 Industry segmentation
FIG. 2 Global onychomycosis treatment market size, 2016 - 2027 (USD Million)
FIG. 3 Growth potential analysis, by type
FIG. 4 Growth potential analysis, by treatment type
FIG. 5 Growth potential analysis, by drug class
FIG. 6 Growth potential analysis, by distribution channel
FIG. 7 Porter’s analysis
FIG. 8 Competitive matrix analysis, 2020
FIG. 9 PESTEL analysis
FIG. 10 Key segment trends, by type
FIG. 11 Key segment trends, by treatment type
FIG. 12 Key segment trends, by drug class
FIG. 13 Key segment trends, by distribution channel
FIG. 14 Key regional trends, by region
FIG. 15 Strategy dashboard, 2020